Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Kaleido Biosciences stock
Learn how to easily invest in Kaleido Biosciences stock.
Kaleido Biosciences Inc is a biotechnology business based in the US. Kaleido Biosciences shares (KLDO) are listed on the NASDAQ and all prices are listed in US Dollars. Kaleido Biosciences employs 82 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Kaleido Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KLDO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kaleido Biosciences stock price (NASDAQ: KLDO)Use our graph to track the performance of KLDO stocks over time.
Kaleido Biosciences shares at a glance
|Latest market close||$2.10|
|52-week range||$2.05 - $20.50|
|50-day moving average||$3.36|
|200-day moving average||$5.60|
|Wall St. target price||$14.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.24|
Buy Kaleido Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kaleido Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kaleido Biosciences price performance over time
|1 week (2022-01-18)||-8.30%|
|1 month (2021-12-23)||-31.15%|
|3 months (2021-10-25)||-50.82%|
|6 months (2021-07-23)||-62.96%|
|1 year (2021-01-25)||-83.12%|
|2 years (2020-01-24)||-72.40%|
|3 years (2019-01-21)||N/A|
|5 years (2017-01-21)||N/A|
Kaleido Biosciences financials
|Gross profit TTM||$-54,992,000|
|Return on assets TTM||-77.39%|
|Return on equity TTM||-276.59%|
|Market capitalisation||$94.1 million|
TTM: trailing 12 months
Kaleido Biosciences share dividends
We're not expecting Kaleido Biosciences to pay a dividend over the next 12 months.
Kaleido Biosciences share price volatility
Over the last 12 months, Kaleido Biosciences's shares have ranged in value from as little as $2.05 up to $20.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kaleido Biosciences's is -0.3864. This would suggest that Kaleido Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Kaleido Biosciences has bucked the trend.
Kaleido Biosciences overview
Kaleido Biosciences, Inc. , a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. It also has a strategic collaboration with the COPD Foundation to study KB109 in patients with chronic obstructive pulmonary disease. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Kaleido Biosciences in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questionsWhat percentage of Kaleido Biosciences is owned by insiders or institutions?
Currently 4.712% of Kaleido Biosciences shares are held by insiders and 81.682% by institutions. How many people work for Kaleido Biosciences?
Latest data suggests 82 work at Kaleido Biosciences. When does the fiscal year end for Kaleido Biosciences?
Kaleido Biosciences's fiscal year ends in December. Where is Kaleido Biosciences based?
Kaleido Biosciences's address is: 65 Hayden Avenue, Lexington, MA, United States, 02421 What is Kaleido Biosciences's ISIN number?
Kaleido Biosciences's international securities identification number is: US4833471000 What is Kaleido Biosciences's CUSIP number?
Kaleido Biosciences's Committee on Uniform Securities Identification Procedures number is: 483347100
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Ask an Expert